Brief: Oscar Health Reaffirm Updated Full Year 2023 Guidance
10/01/2024 11:09
Jan 10 (Reuters) - Oscar Health Inc OSCR.N :
* OSCAR HEALTH INC: REAFFIRM UPDATED FULL YEAR 2023 GUIDANCE
* OSCAR HEALTH INC: ALSO REAFFIRM ITS TARGET OF TOTAL
COMPANY
ADJUSTED EBITDA PROFITABILITY IN 2024
Further company coverage: OSCR.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oscar Health
See all newsBrief: Oscar Health - To Reaffirm Full Year 2026 Guidance At Conference - SEC Filing
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber
U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers Outdoor